Fig. 2From: Associations between proton pump inhibitors and Alzheimer’s disease: a nested case–control study using a Korean nationwide health screening cohortThe odds ratios (95% confidence intervals) of previous proton pump inhibitor (PPI) exposure (left panel) and use duration of PPI (right panel) for AD based on subgroup analysesBack to article page